Heterogeneous tumor evolution initiated by loss of pRb function in a preclinical prostate cancer model

Reginald Hill, Yurong Song, Robert Cardiff, Terry Van Dyke

Research output: Contribution to journalArticle

46 Citations (Scopus)

Abstract

Because each change in the evolution of a cancer is predicated on the effects of previous events, a full understanding of selective changes and their effect on tumor progression can only be understood in the context of appropriate initiating events. Here, we define the effect of pRb function inactivation in prostate epithelium on both the initiation of prostate cancer and the establishment of selective pressures that lead to diminished Pten function and tumor evolution. Using genetically engineered mice, we show that inactivation of the pRb family proteins (Rb/p107/p130) induces epithelial proliferation and apoptosis and is sufficient to produce prostatic intraepithelial neoplasia (PIN) lesions. Over time, adenocarcinomas develop in all mice with no evidence of neuroendocrine tumors. Apoptosis is dependent on Pten function and not p53, unlike other epithelial cell types tested previously. Consequently, Pten hemizygosity reduces apoptosis by 50%, accelerating progression to adenocarcinomas with heterogeneous composition. Heterogeneity is associated with concurrent Pten haploinsufficiency and focal selective progression to complete Pten loss, which yields distinct tumor properties. Given that this analysis models the apparent timing of highly penetrant events in human prostate cancer, observed effects may recapitulate the natural evolution of prostate cancer development.

Original languageEnglish (US)
Pages (from-to)10243-10254
Number of pages12
JournalCancer Research
Volume65
Issue number22
DOIs
StatePublished - Nov 15 2005

Fingerprint

Prostatic Neoplasms
Apoptosis
Neoplasms
Adenocarcinoma
Prostatic Intraepithelial Neoplasia
Haploinsufficiency
Retinoblastoma Protein
Neuroendocrine Tumors
Prostate
Epithelium
Epithelial Cells

ASJC Scopus subject areas

  • Oncology
  • Cancer Research

Cite this

Heterogeneous tumor evolution initiated by loss of pRb function in a preclinical prostate cancer model. / Hill, Reginald; Song, Yurong; Cardiff, Robert; Van Dyke, Terry.

In: Cancer Research, Vol. 65, No. 22, 15.11.2005, p. 10243-10254.

Research output: Contribution to journalArticle

Hill, Reginald ; Song, Yurong ; Cardiff, Robert ; Van Dyke, Terry. / Heterogeneous tumor evolution initiated by loss of pRb function in a preclinical prostate cancer model. In: Cancer Research. 2005 ; Vol. 65, No. 22. pp. 10243-10254.
@article{5610f910b2a742a38dad6662523683f7,
title = "Heterogeneous tumor evolution initiated by loss of pRb function in a preclinical prostate cancer model",
abstract = "Because each change in the evolution of a cancer is predicated on the effects of previous events, a full understanding of selective changes and their effect on tumor progression can only be understood in the context of appropriate initiating events. Here, we define the effect of pRb function inactivation in prostate epithelium on both the initiation of prostate cancer and the establishment of selective pressures that lead to diminished Pten function and tumor evolution. Using genetically engineered mice, we show that inactivation of the pRb family proteins (Rb/p107/p130) induces epithelial proliferation and apoptosis and is sufficient to produce prostatic intraepithelial neoplasia (PIN) lesions. Over time, adenocarcinomas develop in all mice with no evidence of neuroendocrine tumors. Apoptosis is dependent on Pten function and not p53, unlike other epithelial cell types tested previously. Consequently, Pten hemizygosity reduces apoptosis by 50{\%}, accelerating progression to adenocarcinomas with heterogeneous composition. Heterogeneity is associated with concurrent Pten haploinsufficiency and focal selective progression to complete Pten loss, which yields distinct tumor properties. Given that this analysis models the apparent timing of highly penetrant events in human prostate cancer, observed effects may recapitulate the natural evolution of prostate cancer development.",
author = "Reginald Hill and Yurong Song and Robert Cardiff and {Van Dyke}, Terry",
year = "2005",
month = "11",
day = "15",
doi = "10.1158/0008-5472.CAN-05-1579",
language = "English (US)",
volume = "65",
pages = "10243--10254",
journal = "Journal of Cancer Research",
issn = "0099-7013",
publisher = "American Association for Cancer Research Inc.",
number = "22",

}

TY - JOUR

T1 - Heterogeneous tumor evolution initiated by loss of pRb function in a preclinical prostate cancer model

AU - Hill, Reginald

AU - Song, Yurong

AU - Cardiff, Robert

AU - Van Dyke, Terry

PY - 2005/11/15

Y1 - 2005/11/15

N2 - Because each change in the evolution of a cancer is predicated on the effects of previous events, a full understanding of selective changes and their effect on tumor progression can only be understood in the context of appropriate initiating events. Here, we define the effect of pRb function inactivation in prostate epithelium on both the initiation of prostate cancer and the establishment of selective pressures that lead to diminished Pten function and tumor evolution. Using genetically engineered mice, we show that inactivation of the pRb family proteins (Rb/p107/p130) induces epithelial proliferation and apoptosis and is sufficient to produce prostatic intraepithelial neoplasia (PIN) lesions. Over time, adenocarcinomas develop in all mice with no evidence of neuroendocrine tumors. Apoptosis is dependent on Pten function and not p53, unlike other epithelial cell types tested previously. Consequently, Pten hemizygosity reduces apoptosis by 50%, accelerating progression to adenocarcinomas with heterogeneous composition. Heterogeneity is associated with concurrent Pten haploinsufficiency and focal selective progression to complete Pten loss, which yields distinct tumor properties. Given that this analysis models the apparent timing of highly penetrant events in human prostate cancer, observed effects may recapitulate the natural evolution of prostate cancer development.

AB - Because each change in the evolution of a cancer is predicated on the effects of previous events, a full understanding of selective changes and their effect on tumor progression can only be understood in the context of appropriate initiating events. Here, we define the effect of pRb function inactivation in prostate epithelium on both the initiation of prostate cancer and the establishment of selective pressures that lead to diminished Pten function and tumor evolution. Using genetically engineered mice, we show that inactivation of the pRb family proteins (Rb/p107/p130) induces epithelial proliferation and apoptosis and is sufficient to produce prostatic intraepithelial neoplasia (PIN) lesions. Over time, adenocarcinomas develop in all mice with no evidence of neuroendocrine tumors. Apoptosis is dependent on Pten function and not p53, unlike other epithelial cell types tested previously. Consequently, Pten hemizygosity reduces apoptosis by 50%, accelerating progression to adenocarcinomas with heterogeneous composition. Heterogeneity is associated with concurrent Pten haploinsufficiency and focal selective progression to complete Pten loss, which yields distinct tumor properties. Given that this analysis models the apparent timing of highly penetrant events in human prostate cancer, observed effects may recapitulate the natural evolution of prostate cancer development.

UR - http://www.scopus.com/inward/record.url?scp=28544436228&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=28544436228&partnerID=8YFLogxK

U2 - 10.1158/0008-5472.CAN-05-1579

DO - 10.1158/0008-5472.CAN-05-1579

M3 - Article

VL - 65

SP - 10243

EP - 10254

JO - Journal of Cancer Research

JF - Journal of Cancer Research

SN - 0099-7013

IS - 22

ER -